학술논문
A randomized controlled Phase III trial comparing 2-weekly docetaxel combined with cisplatin plus fluorouracil (2-weekly DCF) with cisplatin plus fluorouracil (CF) in patients with metastatic or recurrent esophageal cancer: rationale, design and methods of Japan Clinical Oncology Group study JCOG1314 (MIRACLE study).
Document Type
Article
Author
Source
Japanese Journal of Clinical Oncology; May2015, Vol. 45 Issue 5, p494-498, 5p
Subject
Language
ISSN
03682811